Announcements Trials
Browse Landscape

Status

Recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 3Observational 2

Sponsor

Conditions

Neoplasms 520Breast Neoplasms 457Lung Neoplasms 254Prostatic Neoplasms 234Colorectal Neoplasms 216Carcinoma, Non-Small-Cell Lung 186Pancreatic Neoplasms 154Carcinoma, Hepatocellular 137Stomach Neoplasms 134Ovarian Neoplasms 116Multiple Myeloma 98Head and Neck Neoplasms 94Melanoma 93Esophageal Neoplasms 90Disease 87Urinary Bladder Neoplasms 86Uterine Cervical Neoplasms 78Lymphoma 78Brain Neoplasms 76Hematologic Neoplasms 75Liver Neoplasms 74Endometrial Neoplasms 71Neoplasm Metastasis 66Leukemia, Myeloid, Acute 66Rectal Neoplasms 61Colonic Neoplasms 61Precursor Cell Lymphoblastic Leukemia-Lymphoma 56Sarcoma 53Glioma 53Thyroid Neoplasms 52

Interventions

pexidartinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Observational × Giant Cell Tumor of Tendon Sheath × Clear all
NCT07075471 2025-11-05

Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With Vimseltinib

Deciphera Pharmaceuticals, LLC

Recruiting
100 enrolled

Giant Cell Tumor of Tendon Sheath

NCT04635111 2025-10-06

A Long-term Study Evaluating Hepatotoxicity Associated With TURALIOâ„¢ (Pexidartinib) Treatment

Daiichi Sankyo

Recruiting
30 enrolled

Giant Cell Tumor of Tendon Sheath

Data powered by HemOnc (CC BY 4.0) Colophon âš¡